Regeneron says its COVID-19 antibody cocktail can prevent COVID-19 infections for monthsMarket Watch • 11/08/21
New Phase 3 Analyses Show That a Single Dose of REGEN-COV® (casirivimab and imdevimab) Provides Long-term Protection Against COVID-19PRNewsWire • 11/08/21
Billions Wiped From Covid Pharma Heavyweights—Including Moderna, Regeneron, Merck—As Pfizer's Antiviral Pill Triggers SelloffForbes • 11/05/21
Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/04/21
Regeneron Presentations at ASH Highlight Expanding Clinical Research in Blood Cancers and DisordersPRNewsWire • 11/04/21
Regeneron earnings boosted by $804 million in sales of COVID antibody treatmentMarket Watch • 11/04/21
Is Regeneron Pharmaceuticals (REGN) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 11/03/21
Should You Buy Regeneron Pharmaceuticals (REGN) Ahead of Earnings?Zacks Investment Research • 11/03/21
Will Eylea, Dupixent, REGEN COV Aid Regeneron (REGN) Q3 Earnings?Zacks Investment Research • 11/01/21
Second Dupixent® (dupilumab) Phase 3 eosinophilic esophagitis trial to demonstrate significant disease improvements, underscoring role of type 2 inflammation in this complex diseaseGlobeNewsWire • 10/25/21